This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Greatbatch Appoints New CFO And CTO To Advance Medical Device And Systems Strategy

Marco Benedetti, currently corporate controller and principal accounting officer, will transition to the role of vice president responsible for financial planning & analysis and investor relations functions for the company.

CTO Appointment

Dr. Kaiser will immediately assume the company’s newly-created CTO position, where he will serve as the leader of QiG Group – Greatbatch’s research and development subsidiary – and also provide strategic guidance and technical leadership to the Greatbatch Medical and Electrochem businesses.

Since joining Greatbatch in 2008, Dr. Kaiser has taken on increasing responsibility in a number of key leadership roles in product planning, marketing, and development. His most recent role included leading the product development, design assurance, and regulatory affairs for QiG Group’s Cardiovascular Portfolio. Prior to joining Greatbatch, he held positions of progressive responsibility within established medical device companies such as Medtronic, Inc. and Guidant Corporation, led the research efforts of a large Cardiology private practice at the St. Paul Heart Clinic, and fostered research and innovation at the academic level with over 23 publications as an adjunct assistant professor at the University of Minnesota. Dr. Kaiser, who received a Bachelors of Science in Electrical Engineering from the University of Wisconsin – Madison, and a MS and Ph.D. in Biophysical Sciences and Medical Physics from the University of Minnesota, is the inventor or co-inventor of 10 granted and pending patents.

“Dan has demonstrated exceptional performance in navigating our cardiovascular portfolio, including spearheading five product approvals. His leadership of QiG Group will be essential as we drive the commercialization phase of our medical device and systems strategy,” said Mr. Hook.

QiG Group was previously led by Mr. Hook, under whose leadership it has grown to more than 150 highly skilled research and development Associates.

About Greatbatch

Greatbatch, Inc. (NYSE: GB) provides top-quality technologies to industries that depend on reliable, long-lasting performance through its brands Greatbatch Medical, Electrochem and QiG Group. Greatbatch Medical develops and manufactures critical medical device technologies for the cardiac, neurology, vascular and orthopaedic markets. Electrochem designs and manufactures battery and wireless sensing technologies for high-end niche applications in the energy, military, portable medical, and other markets. The QiG Group empowers the design and development of new medical devices for our core markets. Additional information about the Company is available at

Copyright Business Wire 2010
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.03 -2.90%
FB $116.73 7.20%
GOOG $691.02 -2.10%
TSLA $247.54 -1.60%
YHOO $36.59 -0.97%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs